OBI Pharma has received clearance from the US FDA for an IND application for OBI-902 to begin a Phase I/II trial for advanced ...

Veraxa Biotech has entered a joint discovery partnership with OmniAb tp develop a bispecific antibody drug conjugate (bsADC) ...

The research centered on bacterial conjugation, the process by which bacteria share genetic material, including antibiotic resistance. Hebrew University scientists led by Professors Sigal Ben ...

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

This helps the bacteria spread resistance genes, even in conditions previously thought to be less favorable for conjugation. "This process of DNA transfer, called bacterial conjugation ...

Starting at 7:30 p.m. inside the Providence Farm Chapel, the show is an entirely acoustic, unplugged, candlelit performance.

This contract marks the first official step in the full-scale operation of the ADC manufacturing facility at the Syracuse Bio ...

Students stroll into the classroom on a sunny afternoon. They fall into their assigned seats, open their laptops, and lean in ...

Highly experienced in gene therapy dealmaking, Pettenaro will be driving Coave’s business development activities and ...